Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075105 Target Snapshot

Protein tyrosine phosphatase type IVA 2 · SINGLE PROTEIN · Homo sapiens

32Compounds
10Assays
1Approved Drugs
33.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q12974. Use UniProt Q12974 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q12974 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein tyrosine phosphatase type IVA 2 as ChEMBL target CHEMBL1075105, mapped to UniProt Q12974. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein tyrosine phosphatase type IVA 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1075105
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q12974
Protein tyrosine phosphatase type IVA 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein tyrosine phosphatase type IVA 2 is the right protein anchor across sources, using UniProt Q12974 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein tyrosine phosphatase type IVA 2
UniProt AccessionQ12974
Component TypeProtein
Sequence Length167 aa

Protein tyrosine phosphatase type IVA 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein tyrosine phosphatase type IVA 2, mapped to UniProt Q12974. Sequence length is 167 aa.

Mapped IDQ12974
Review nameProtein tyrosine phosphatase type IVA 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5033.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4445621 7.28 IC50 52.0 Preclinical
CHEMBL3393171 6.89 IC50 130.0 Preclinical
CHEMBL55 6.52 IC50 300.0 Approved
CHEMBL1088572 6.5 IC50 314.0 Preclinical
CHEMBL3393148 4.5 IC50 31400.0 Preclinical
CHEMBL3393149 4.16 IC50 69400.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
0
6.0
5
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PENTAMIDINE
CHEMBL55
Approved 1984
Assay Landscape

Assay Landscape

10
Total Assays
12
Tested Compounds
1
Assay Types
Binding — 10 assays, 12 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 5 10 5.4
assay format 4 2 6.8
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine